Literature DB >> 28679986

Virus-specific cytotoxic T cells in chronic active Epstein-Barr virus infection.

Haruna Shibayama1,2, Ken-Ichi Imadome3, Erika Onozawa1,2, Akiho Tsuzura1, Osamu Miura1, Takatoshi Koyama2, Ayako Arai1,2.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) is a disease characterized by clonally proliferating and activated EBV-infected T or NK cells accompanied by chronic inflammation and T- or NK-cell neoplasms. However, the mechanism for developing CAEBV has not been clarified to date. Because the decreased number or inactivation of EBV-specific cytotoxic T lymphocytes (CTLs) resulted in the development of EBV-positive B-cell neoplasms, we investigated the number of CTLs in CAEBV patients using the tetrameric complexes of HLA-restricted EBV-specific peptides. Among the seven patients examined, EBV-specific CTLs were detected in the peripheral blood mononuclear cells (PBMCs) of four cases but were not detected in three cases. The ratio of EBV-specific CTLs in PBMCs tended to be higher in the patients with active disease than in those with inactive disease. In two patients in whom EBV-specific CTLs had not been detected, CTLs appeared after the eradication of EBV-infected T cells by allogeneic bone marrow transplantation. These results suggested that the failure of CTLs had a role in developing CAEBV, although the induction number and function of EBV-specific CTLs might vary in each patient.

Entities:  

Keywords:  Chronic active Epstein-Barr virus infection; Cytotoxic T lymphocyte

Mesh:

Substances:

Year:  2017        PMID: 28679986     DOI: 10.11406/rinketsu.58.583

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

1.  NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.

Authors:  Sho Shibata; Yoko Takiuchi; Naoto Kawasaki; Yoshio Okamoto; Shojiro Inano; Akiko Fukunaga; Sumie Tabata; Ayako Arai; Ken-Ichi Imadome; Toshiyuki Kitano
Journal:  Int J Hematol       Date:  2022-01-10       Impact factor: 2.490

2.  Fatal Systemic Vasculitis Associated with Chronic Active Epstein-Barr Virus Infection.

Authors:  Oumama Jamal; Nawal Sahel; Rachida Saouab; Mohammed El Qatni; Meryem Zaizaa; Ilyas El Kassimi; Adil Rkiouak; Salaheddine Hammi; Youssef Sekkach
Journal:  Mo Med       Date:  2021 May-Jun

Review 3.  Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.

Authors:  Ayako Arai
Journal:  Microorganisms       Date:  2021-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.